a strategic consulting firm with 20 years of experience applying expertise in health economics and outcomes research, reimbursement, health policy, market research, and market access strategy to support global pharmaceutical companies, as well as emerging pre-commercialization phase firms. We help our clients solve real-world challenges such as developing an evidence package to optimize access in key global markets, predicting product performance, and identifying reimbursement strategies and programs to maximize patient access. From development through market maturity, Xcenda helps manufacturers identify, demonstrate, and deliver their brand’s value proposition to key healthcare stakeholders.